The FDA is holding a public workshop, “Nonprescription Analgesic/Antipyretic Drug Development in Children 2 to Less Than 12 Years of Age.” The goal of the workshop is to discuss nonprescription pain (analgesic) and fever (antipyretic) treatment options available for children 2 to less than 12 years of age, and whether additional oral nonprescription treatment options containing acetaminophen and/or nonsteroidal anti-inflammatory drugs are needed for pain, fever or both.
The workshop